Skip to content

Free shipping over $111.71 · Third-party tested · For research use only

Helica Labs HELICA LABS
Liraglutide

Weight Loss & Metabolic

Liraglutide

Liraglutide is a long-acting GLP-1 receptor agonist approved as a prescription medication for type 2 diabetes and obesity, used in metabolic research.

$59.43 / vial

−%

/ vial

Out of Stock

Buy 10+, save 20%

Get an email when it's back

This strength is sold out right now. Leave your email and we'll write as soon as it's back in stock.

One email when it's back, nothing else. This is not a newsletter sign-up.

Payment: crypto (USDC, BTC, ETH, SOL …) New to crypto? 5-minute guide

What it is

Liraglutide shares 97% sequence homology with native human GLP-1 and is acylated with a C-16 fatty acid enabling albumin binding and a half-life of approximately 13 hours, suited to once-daily subcutaneous injection. It is marketed as Victoza (diabetes) and Saxenda (weight management). For research use only. Not for human use.